Absorption |
Blood-Brain Barrier | BBB+ | 0.7100 |
Human Intestinal Absorption | HIA+ | 1.0000 |
Caco-2 Permeability | Caco2+ | 0.7737 |
P-glycoprotein Substrate | Substrate | 0.7307 |
P-glycoprotein Inhibitor | Inhibitor | 0.6937 |
Inhibitor | 0.8987 |
Renal Organic Cation Transporter | Non-inhibitor | 0.6735 |
Distribution |
Subcellular localization | Mitochondria | 0.4329 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.6766 |
CYP450 2D6 Substrate | Substrate | 0.6722 |
CYP450 3A4 Substrate | Substrate | 0.7094 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.8567 |
CYP450 2C9 Inhibitor | Inhibitor | 0.8303 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.8703 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.7220 |
CYP450 3A4 Inhibitor | Inhibitor | 0.8692 |
CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.6607 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8131 |
Inhibitor | 0.6769 |
AMES Toxicity | Non AMES toxic | 0.5664 |
Carcinogens | Non-carcinogens | 0.5495 |
Fish Toxicity | High FHMT | 0.9925 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9066 |
Honey Bee Toxicity | Low HBT | 0.6944 |
Biodegradation | Not ready biodegradable | 0.8789 |
Acute Oral Toxicity | III | 0.5138 |
Carcinogenicity (Three-class) | Non-required | 0.5972 |